drug protocol number

CABL001ASA

drug sponsor

Novartis

drug study

Scemblix (Asciminib/ ABL001)

drug trial site

King Abdulaziz Medical City NG (Riyadh),King Abdulaziz Medical City NG (Jeddah),King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh)

drug status

Ongoing

drug phase